Journal of Clinical Trials
Open Access

Department of Cardiology, Aswan University, Cairo, Egypt

Biography

Dr. Mohamed Kamal Salama is the Cardiovascular health insurance consultant.He is the lecturer of cardiology kafer elshakh university hospital PhD in Heart, Tanta University. He is the Member of the Egyptian Society of Cardiology and the Former head of the heart department in Aswan University.

Publications

• Research Article   
  Assessment of the Relationship between Galectine-3 and Cardiac Functions in Patients with Chronic Heart Failure
  Author(s): Saud Mohamed Elsaughier*, Mohamed Kamal Salama, Amr Hanafy, Mahmoud M Ahmed and Ayman M Ibrahim
  
  Background: HF biomarkers have growing importance in daily clinical practice as well as in clinical trials. Several biomarkers are used for diagnosis and prognosis of HF patients. Recently, Galectine-3 has been proposed for diagnosis and prognosis of HF. In this study we aimed to determine the relationship between galectine-3 level and cardiac functions in patients with chronic heart failure and its correlation with clinical manifestations. Methods: The current study enrolled 90 patients with chronic heart failure and then divided according to ejection fraction (EF) into two groups , group I included 60 patients with clinical manifestation of HF and EF <50%, group II included patients with clinical manifestation of HF and EF >50%.serum levels of Galectine-3 were measured in all patients with heart failure. Results: Level of galectine-3 was significantly increasing with advancing.. View More»
  DOI: 10.35248/2167-0870.20.10.408

  Abstract HTML PDF